American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Accustem Sciences Inc. (ACUT)

$0.23 +12.20% OTC: ACUT · 15-min delayed

NEW YORK, New York
Public · OTC: ACUT

Visit website Follow

-$1.8MNet income

ACUTOTC

About Accustem Sciences Inc.

ACCUSTEM SCIENCES INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: ACUT
Headquarters: NEW YORK, New York
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: ACUT OTC
SEC CIK: 1850767
SIC: 2834 Pharmaceutical Preparations

Embed this company’s badge

Show Accustem Sciences Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/accustem-sciences-inc/"><img src="https://americancompanies.com/badge/accustem-sciences-inc.svg" alt="Accustem Sciences Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Accustem Sciences Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: -$1.8M
Total assets: $1.5M

Source: SEC EDGAR · updated Jun 7, 2026

OTC: ACUT

$0.23 +12.20%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.16 $2.21

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Accustem Sciences Inc. (ACUT) Stock Price

Reported a net loss of $1.8M.
Trading 90% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Accustem Sciences Inc..

Write a review

Newsroom

News about Accustem Sciences Inc.

AccuStem Sciences to Present at the Life Sciences Virtual Investor Forum September 18th GlobeNewswire Inc. · 2025-09-16 · positive AccuStem Sciences, Inc. Announces Chairman Purchase of Shares GlobeNewswire Inc. · 2025-06-16 · positive AccuStem Sciences, Inc. Announces Chairman Purchase of Shares GlobeNewswire Inc. · 2025-04-10 · positive AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States GlobeNewswire Inc. · 2025-04-04 · positive AccuStem Sciences, Inc. Announces Acquisition of Proprietary MSC Lung Cancer Screening Test Benzinga · 2025-03-18 · positive AccuStem Sciences, Inc. Announces Chairman Purchase of Shares GlobeNewswire Inc. · 2025-01-03 · positive

News & sentiment via Polygon.io

FAQ

Accustem Sciences Inc.: frequently asked questions

Is Accustem Sciences Inc. an American company?

Accustem Sciences Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Accustem Sciences Inc. headquartered?

Accustem Sciences Inc. is headquartered in New York, New York, United States.

Is Accustem Sciences Inc. publicly traded?

Yes — Accustem Sciences Inc. is a publicly traded company. Its stock trades under the ticker symbol ACUT on the OTC.

What does Accustem Sciences Inc. do?

Accustem Sciences Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore